Validation and Evaluation of a Newly Developed Mobile Diet App

January 26, 2023 updated by: Jazlina binti Syahrul, Universiti Putra Malaysia

Validation and Evaluation of a Newly Developed Mobile Diet App for Enhancing Dietary Adherence for Patients With Chronic Kidney Disease (CKD)

A 12-week, prospective, multicenter, open-label pilot randomized controlled trial (RCT) will be carried out to determine the feasibility, acceptability and potential clinical efficacy of a newly developed mobile diet app among CKD populations at different stages in Malaysia. Participants will be randomly assigned into either (i) intervention group (mobile diet app) or (ii) control group (dietary counseling using conventional pamphlet).

Study Overview

Detailed Description

General Objective: To evaluate a newly developed mobile diet app in enhancing dietary adherence for patients with chronic kidney disease.

Specific Objectives:

  1. To validate the newly developed mobile diet app for patient with chronic kidney disease.
  2. To determine the feasibility and acceptability of this newly developed mobile diet app among patients with chronic kidney disease.
  3. To evaluate the preliminary efficacy of the newly developed mobile diet app in enhancing dietary adherence in patients with chronic kidney disease

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Nor Fadhlina binti Zakaria, Nephrologist
  • Phone Number: +603 8947 2561
  • Email: fadhsara@yahoo.com

Study Locations

    • Selangor
      • Serdang, Selangor, Malaysia, 43000
        • Recruiting
        • Hospital Serdang
        • Contact:
          • Nor Fadhlina binti Zakaria, Nephrologist
          • Phone Number: +603 8947 2561
          • Email: fadhsara@yahoo.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Clinically diagnosed CKD / eGFR < 60 ml/min/1.73m2 for ≥ 3 months (only applicable to pre-dialysis patients.
  2. Undergone maintenance dialysis for at least 3 months (only applicable to dialysis patients)
  3. Possessing smartphone and is willing to use health app
  4. Alert and oriented
  5. At least 18 years of age

Exclusion Criteria:

  1. Inability to use the smartphone app (e.g. due to vision problems)
  2. Hard to comply with home monitoring (e.g. suffering from anxiety or depression)
  3. Refuse to comply with dietary prescription
  4. Patients who participate in other study at the same time
  5. Patients who have participated in another research study involving an investigational product in the past 12 weeks preceding enrollment.
  6. Planning for kidney transplant over the study duration.
  7. Female patients who are pregnant, lactating or planning a pregnancy during the course of the trial.
  8. Participants who are receiving nutritional support (i.e. enteral and intra-venous route).
  9. Participants who are currently receiving active treatment for cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Counseling + Renal Diet App
Subjects in the intervention group will receive an individualized dietetic counseling from the researcher aided with the newly developed renal diet app for educative purpose and aiding tool to enhance the dietary adherence among CKD patients
Subjects in the both arms will receive individualized dietetic counseling as the standard dietetic care in Malaysia
Individualized dietetic counseling aided with a newly developed renal diet app for educative purpose and aiding tool to enhance the dietary adherence among CKD patients. Training on the use of the app will be provided to the subjects prior to the commencement of the intervention. Subjects will be trained on the use of the home screen, icons, feedback screens, the process of entering dietary and fluid intake data and selecting portion sizes. Subjects are considered as competent users when they could correctly record the foods and drinks with correct portion size eaten in the past 24 hours and successfully save the data.
Other Names:
  • MyNutriKidney
Placebo Comparator: Counseling + Printed Nutrition Pamphlet
Individualized dietetic counseling aided with printed nutrition pamphlet prepared by Ministry of Health, Malaysia
Subjects in the both arms will receive individualized dietetic counseling as the standard dietetic care in Malaysia

After the counseling session, a standardized renal nutrition pamphlet prepared by dietitians from Universiti Putra Malaysia and Hospital Serdang will be given for patient's educative purpose.

Since the mobile application is intended for patient's education and self-monitoring (food diary) purposes, and thus, to ensure the comparability between intervention and control groups, the patients in control group will be trained to record their diet intakes manually using the recommended approach 3-day diet records. Nutritional feedback or advices on the diet records will be given to the participants during follow up sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glomerular Filtration Rate (eGFR)
Time Frame: 3 months
Estimated glomerular filtration rate (eGFR) will be recorded in of mL/min/1.73m2.
3 months
Serum Kidney Function Test
Time Frame: 3 months

Routine collected biochemical results from the patients' medical records:

- urea, sodium, chloride, potassium and creatinine will be measured in mmol/L

3 months
Serum Hemoglobin A1C Test
Time Frame: 3 months
Routine collected biochemical results from the patients' medical records for HbA1C (%)
3 months
Serum Blood Sugar Profile
Time Frame: 2 weeks
Routine collected biochemical results from the patients' medical records and blood sugar (mmol/L) also will be recorded if patient had done self-monitoring blood glucose at home
2 weeks
Albuminuria
Time Frame: 12 weeks
Routine collected urine analysis to measure urine albumin (mg) if there is presence of albumin or protein
12 weeks
Dietary History
Time Frame: 6 weeks
Three-day diet records (3DDR) : 2 days weekdays + 1 weekend / dialysis and non-dialysis day. Measured unit is in kilocalories (kcal)/day
6 weeks
Dietary Adherence
Time Frame: 6 weeks

End Stage Renal Disease Adherence Questionnaire (ESRD-AQ):

- validated questionnaires which consists of 4 subscales pertaining dialysis, medication, dietary and fluid adherences. Patients will need to rate their fluid and dietary adherence on a numerical rating scale which composed of 0% (None of the time) to 100% (All of the time).

6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the app: interview
Time Frame: 12 weeks
The feasibility of the app will be measured by the app usage. Study participants will be interviewed for app usage in term of frequency (e.g. in average how many days of usage in a week) and extent of its usage (e.g. how much time has spent on the app in a day). The intervention (mobile diet app) is consider feasible if the subject used the app more than 50% of study duration which is 42 days (6 weeks).
12 weeks
Acceptability: User Acceptance test (UAT)
Time Frame: 12 weeks
Acceptability of the app will be measured using User Acceptance test (UAT). It consisted of 11 items and each item was rated on a 5-point Likert scale (1 = Strongly disagree, 3 = neutral, and 5 = Strongly agree).
12 weeks
Users Satisfaction: Likert scale
Time Frame: 12 weeks
The evaluation questionnaire included 7 items evaluated using a five-point Likert scale (1 = Strongly disagree, 3 = neutral, and 5 = Strongly agree) on the composition of the app, on the design and layout of the app, and overall satisfaction.
12 weeks
Health Behaviour
Time Frame: 12 weeks
A set of self-developed items will be used to assess the patient's perceptions of dietary adherence based on HBM constructs. Content validity have been done by 3 experts with the reported S-CVI/UA of 0.93. This part consisted of 28 items derived from available literatures, assessing different constructs of HBM
12 weeks
Nutrition Literacy
Time Frame: 12 weeks
A dialysis-specific nutrition-related health literacy has been developed based on health literacy theory model (Sørensen et al., 2012) by the researchers and validated among HD patients with the content validity measured by S-CVI/AVE of 0.96 and construct validity measured by average variance extract (AVE) of 0.589 as well as composite reliability of 0.877 (unpublished data).
12 weeks
Nutritional Status
Time Frame: 12 weeks
Anthropometry data will be collected by researchers at 2 time points, baseline (V0) and study end-point (V2). Malnutrition inflammation score (MIS) will be used to assess patient's nutritional status (Kalantar-Zadeh, Kopple, Block & Humphreys, 2001).
12 weeks
Dietary Knowledge
Time Frame: 12 weeks
The kidney disease-related dietary knowledge questionnaire was modified from (Durose et al., 2004) based on the Malaysian MNT Guidelines for CKD, (MDA, 2005) which was adopted from the K-DOQI guidelines (NKF 2000; NKF 2003).
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zulfitri 'Azuan bin Mat Daud, Lecturer[Dr], Universiti Putra Malaysia
  • Principal Investigator: Barakatun Nisak binti Mohd Yusof, Lecturer[Dr], Universiti Putra Malaysia
  • Principal Investigator: Lim Jun Hao, Dietitian, Universiti Putra Malaysia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 15, 2023

Primary Completion (Anticipated)

March 30, 2023

Study Completion (Anticipated)

April 30, 2023

Study Registration Dates

First Submitted

March 19, 2020

First Submitted That Met QC Criteria

April 6, 2020

First Posted (Actual)

April 7, 2020

Study Record Updates

Last Update Posted (Actual)

January 27, 2023

Last Update Submitted That Met QC Criteria

January 26, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • NMRR-19-3569-50972

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Diseases

Clinical Trials on Counseling

Subscribe